CClinicalTrials.gg
CompletedNCT06616662Updated Sep 27, 2024

Transsphincteric Fistula Management Using LIFT and MAF

An observational study in Perianal Fistula, sponsored by Zagazig University. Completed at 1 site in Egypt. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-09-27.

Sponsored by Zagazig University · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
257
Ages
18 Years and older
Sex
All
01

Study summary

a study that detect the most suitable surgical techniques for treating transsphincteric fistula

Read the detailed description

we compared between LIFT and MAF in elderly with PAF

02

Conditions studied

  • Perianal Fistula

Keywords

  • perianal fistula,flap,ligation
03

In context

Rectal Fistula

189 studies on the registry are indexed under Rectal Fistula; 42 are open to participants now.

This study's enrollment of 257 is above the median of 94 across 50 observational studies indexed under Rectal Fistula.

Browse Rectal Fistula studies →

Lead sponsor

Zagazig University is the lead sponsor of 447 studies on the registry; 75 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

two hundred and fifty seven elderly patient with PAF

Inclusion criteria

  • elderly persons with PAF

Exclusion criteria

Exclusion Criteria:

  • recurrent fistula
  • associated autoimmune diseases
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
257 participants (actual)
Patient registry
No

Groups and cohorts

  • LIFT

    Procedure: LIFT

  • MAF

    Procedure: MAF

Interventions

  • ProcedureMAF

    use mucosal advancement flap to treat PAF

  • ProcedureLIFT

    use LIFT surgery for treating PAF

06

What researchers measure

Primary outcomes

  1. healing rate

    incidence of healing in both approaches

    Time frame: three years

Secondary outcomes

  1. incontinence

    incidence of incontinence after both approaches

    Time frame: three years

07

Study locations

1 site
  • Faculty of Medicine Zagazig University
    Zagazig, Sharkia 44511, Egypt
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 27, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06616662
Lead sponsor
Zagazig University
Responsible party
Tamer.A.A.M.Habeeb (prof of general and laparoscopic surgery, Zagazig University) — Principal investigator
First posted
Sep 27, 2024
Start date
Jul 1, 2018
Primary completion
Jul 1, 2021
Completion
Jul 1, 2024
Last update
Sep 27, 2024

Study contacts

Tamer. A.A.M. Habeeb
principal investigator · Zagazig University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion